Parkinson's treatment update. Nice to see that news is released to the media on a regular basis.
8:02AM NuPathe announces allowance of additional US patent application for NP201 (PATH) 3.32 : Co announces that the USPTO has issued a notice of allowance for U.S. Patent application 11/784,526 entitled "Implants for the Treatment of Dopamine Associated States." This application relates to methods for treating dopamine associated states (such as Parkinson's disease) using a biodegradable polymer implant capable of delivering a dopamine modulating compound gradually rather than with an initial burst and maintaining an effective plasma level of the compound for a specified delivery period.
Given this action, NuPathe expects the patent to issue within the next few months. Once issued, it will provide patent protection into October 2027 for NP201, NuPathe's long-term biodegradable ropinirole implant for the treatment of Parkinson's disease and other dopamine associated disorders. NuPathe has additional licensed patent applications pending in the U.S. and other territories for NP201.